Netherlands
Initial Capital in $1.9m round for BUX
Business to target growth in additional European markets
Forbion closes co-investment fund on €75m
Fund has already made three investments
HenQ closes third fund on €50m
Vehicle to target both seed and <€10m follow-up rounds
Liberty and Volta in €2m series-A for LookLive
Business targeting new partnerships with broadcast and retail brands
Main Capital holds €85m final close for fourth fund
Fund surpasses €75m target to hit hard-cap
Vendis backs Humanoid BIMBO
Final deal for GP's €111.5m first fund
Avista's Trimb acquires YouMedical
Acquisition forms part of nothern European buy-and-build platform
NVP appoints former deputy prime minister as chair
Move takes place as industry comes under mounting public scrutiny
Van den Ende launches €107m fund; rebrands as Endeit
Firm to be renamed to Endeit Capital
Sofinnova et al. in €72.8m series-C round for Merus
Third largest round observed by unquote" in Benelux so far in 2015
PHSC's Skin Vision raises €3m
Fund was led by Danish pharma company Leo Pharma
Fee transparency debate takes hold in Netherlands
Increasing pressure coming from LPs around fees hits GPs in the Netherlands
CD&R's Mauser to raise $100m in IPO
Mauser Group, a packaging manufacturer owned by Clayton Dubilier & Rice (CD&R) since 2014, is looking to raise $100m in its upcoming listing on the Nasdaq.
Lead Edge et al. in $82m series-C for Catawiki
Largest funding round in Benelux so far in 2015, according to unquote” data
Arle and Eyrir in €706m Fokker exit
Arle to reap €500m in cash on sale of majority stake
TDR in €3.7bn LBO for LeasePlan
Fourth largest transaction ever in Benelux, according to unquote” data
Gilde et al. to de-list TenCate in €675m take-private
Transaction sees business leave stock exchange after sixty years
Main Capital fully divests VisionWaves to IFS
Buyer had prior business partnership with VisionWaves
Apax to acquire RFS Holland
SBO thought to value business around the €450m mark
Naxicap's Accent bolts on Covebo
Sixth add-on for Accent since being it first received PE backing
VC-backed Kiadis Pharma lists with €166.4m market cap
Shareholders to invest a combined €12m as part of flotation
VC-backed Kiadis Pharma lists with €166.4m market cap
Shareholders to invest a combined €12m as part of flotation
Flytxt raises $11m from Sunrise et al.
Data analytics company is aiming to double current workforce
Main Capital acquires majority stake in Roxit
Transaction is the largest by Main Capital to date